Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/32486
Title: Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.
Authors: 
Mesh: 
Issue Date: 4-Apr-2017
Citation: Neurology.2017 Apr;(88)14:1321-1328
Abstract: To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.
PMID: 28283596
URI: https://hdl.handle.net/20.500.12530/32486
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC5379931.pdf505.73 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.